Search This Blog

Tuesday, April 3, 2018

103



This was originally published here, in French (link).
We provide this translation for your convenience. Practical aspects may differ where you live.




ICCARRE in Moscow

By Charles-Edouard!


ICCARRE-Le-Grand at the Tsars


After the success of the presence, noticed (since ignored by the medical-pharmaceutical underworld), of 4/7 at IAS-2017, ICCARRE is announced at VI International Eastern Europe and Central Asia AIDS Conference 2018, in Moscow.
Sounds a bit like Tintin in the Land of the Soviets... You won't be there, neither will I... Here is an exclusive preview(the company does not shy away from any sacrifice...) of the patient cases that will be presented. There are about ten of them... So I put 3 of them here, and I will put the others as we go along.

Patient #1: in 1/7 since 2009


8 years of treatment for only 1 toxicity! Here is the work... This is a patient case, sourced by J. Leibowitch, and therefore duly registered in Pr Péronne's department, in Garches. Don't tell us (or insinuate) that it doesn't exist!
As you can see on the graph, the patient had 2 treatment interruptions (therapeutic vacations) before maintaining, in a continuous and uninterrupted way, her undetectable CV. This illustrates the clear advantage to ICCARRE, which provides both therapeutic benefit and reduced toxicity.

Patient #2: in 2/7 since 2011


7 years of treatment for only 1 toxicity! An ICCARRE-le-Grand not too advanced, cushy, in 2/7. 15 years of benevolent treatment. Oh, how envious I am!
No mystery, today like yesterday, you have to run all over Paris to find a doctor who can handle it... When I compare it to my own doctor, it's light years away. And my doctor is not a light, he's nice, but on this one, he's a bit of a pushover. Besides, I only listen to him with a distracted ear...

Under ICCARRE (#3): 2 natural births


Well... There are people in life who think that everything stops for them... The veterans knew how to wait a little before entering the treatment. Yéni or Morlat recommendations? I don't give a damn! Oh my, how hateful is all this over-medication...

And this haughty contempt!

What a nice denial inflicted to the stipendiated morons... Brrr... Just to think that these people would like to forbid us, us honnites, to reproduce.
Hi, Hi, Hi, we're getting there with the kiki!

10 patient cases for ICCARRE 1/7


That's a lot! It makes for a nice, convincing presentation... We will explore them one by one, otherwise we will have indigestion. The Russians, familiar with American-style 'fake news', will appreciate it!

In the news


The question of the super mutation (known as 3'PPT) in vivo is on everyone's mind. It has been detected in only 1 patient, in DOMONO, for a rise to ...798... Well... Super mutation?... The authors also indicate: [pre-existing] Proviruses containing a single INSTI-RAM is the mechanism of failure. This is very much in line with the Achilles Heel warning.

- Morlat was completely off the mark regarding the 'threshold' dose for NVP; this was highlighted by the VERxVE trial found here: 4 to 8 times overdose! Trust them, they tell us... We will come back to this!

- A new article without much interest: Dolutegravir resistance mutations

The French genius


Francis Blanche does the product placement trick on TV. Is this a bygone era? Well, no... With monetization (You Tube), the activists in robes take advantage of it to throw us medicaments at all costs!

Feel free to comment, like, share and use

good weekend, good stuffing and not too many meds ... Huh?

No comments: